Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 3Terminated 2Withdrawn 1Unknown 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Urinary Bladder Neoplasms 6Colorectal Neoplasms 4Carcinoma, Transitional Cell 4Non-Muscle Invasive Bladder Neoplasms 3Neoplasm Metastasis 3Colonic Neoplasms 3Anus Neoplasms 3Sarcoma 2Rectal Neoplasms 2Pancreatic Neoplasms 2Neoplasms 2Carcinoma in Situ 2Virus Diseases 1Urologic Neoplasms 1Urologic Diseases 1Urogenital Neoplasms 1Urinary Bladder Diseases 1Neoplasms by Site 1Neoplasm Recurrence, Local 1Nasopharyngeal Carcinoma 1Mycobacterium Infections 1Head and Neck Neoplasms 1Epstein-Barr Virus Infections 1Disease 1Dermatitis 1Carcinoma, Hepatocellular 1Adenoviridae Infections 1

Interventions

Gemcitabine 100130-nm albumin-bound paclitaxel 34Oxaliplatin 28Capecitabine 27Fluorouracil 25Albumin-Bound Paclitaxel 23Leucovorin 19Irinotecan 18Erlotinib Hydrochloride 14Cyclophosphamide 12Radiosurgery 11pembrolizumab 10Radiotherapy 10Nivolumab 10Bevacizumab 10Surgical Procedures, Operative 9avelumab 7Docetaxel 7Taxes 6Cisplatin 6ruxolitinib 5folfirinox 5Specimen Handling 5Paclitaxel 5Everolimus 5Cetuximab 5ALT-803 5trametinib 4spartalizumab 4fludarabine 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Pancreatic Neoplasms × Mitomycin × Clear all
NCT00276744 2018-10-24

Individualized Drug Treatment for Treating Patients With Pancreatic Cancer

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Terminated
249 enrolled 4 charts
Gastrointestinal

Pancreatic Neoplasms

NCT00967291 2012-02-01

PACT-11

IRCCS San Raffaele

Phase 2 Terminated
21 enrolled
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡